Basic Information | Post buying leads | Suppliers | Cas Database |
(S)-2-[(2R,6S)-6-(2-propionyloxy-2-phenylethyl)-1-methylpiperidin-2-yl]-1-phenylethanone
Lobeline hydrochloride
Conditions | Yield |
---|---|
With hydrogenchloride In methanol Heating; |
C25H33NO3
Lobeline hydrochloride
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: CrO3; H2SO4 / acetone / 1 h / 20 °C 2: aq. HCl / methanol / Heating View Scheme |
2,2′-((2,6)-1-methylpiperidine-2,6-diyl)bis(1-phenylethanone) hydrochloride
Lobeline hydrochloride
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: 65 percent / NaBH4 / methanol / 20 °C 2: 92 percent / (S)-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole; Na2SO4 / CDCl3 / 48 h / 20 °C 3: CrO3; H2SO4 / acetone / 1 h / 20 °C 4: aq. HCl / methanol / Heating View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 92 percent / (S)-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole; Na2SO4 / CDCl3 / 48 h / 20 °C 2: CrO3; H2SO4 / acetone / 1 h / 20 °C 3: aq. HCl / methanol / Heating View Scheme |
(cis:trans)-(-)-lobeline
Lobeline hydrochloride
Conditions | Yield |
---|---|
With hydrogenchloride In water; isopropyl alcohol at 60℃; for 8h; Inert atmosphere; |
Lobeline hydrochloride
Conditions | Yield |
---|---|
With thionyl chloride In chloroform at 20℃; for 24h; Chlorination; | 80% |
Lobeline hydrochloride
cis-2S,6R-N-methyl-6-phenacyl-2-trans-styrylpiperidine
Conditions | Yield |
---|---|
With phosphonic Acid at 45 - 50℃; for 22h; Dehydration; | 75% |
Lobeline hydrochloride
(S)-2-[(2S,6R)-1-Methyl-6-((E)-styryl)-piperidin-2-yl]-1-phenyl-ethanol
Conditions | Yield |
---|---|
With hydrogenchloride; mercury; zinc for 0.25h; Dehydration; reduction; Heating; | 46% |
Conditions | Yield |
---|---|
With sodium hydrogencarbonate In water for 48h; |
Lobeline hydrochloride
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 75 percent / 85 percent aq. H3PO3 / 22 h / 45 - 50 °C 2: H2 / 5 percent Pd/C / methanol / 1.5 h / 2585.74 Torr 3: pyridinium dichromate / CH2Cl2 / 3 h / 20 °C View Scheme |
Chemical Name: alpha-Lobeline hydrochloride
IUPAC NAME: 2-[(2R,6S)-6-[(2R)-2-Hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanone hydrochloride
CAS No.: 134-63-4
EINECS: 205-150-2
RTECS: OJ8490100
Molecular Formula: C22H28ClNO2
Molecular Weight: 373.92 g/mol
Melting Point: 183-185 °C (dec.)(lit.)
Flash Point: 247.5 °C
Boiling Point: 485.6 °C at 760 mmHg
Following is the structure of Lobeline hydrochloride (134-63-4):
Product Categories are Alkaloids ; Heterocyclic Compounds ; Biochemistry ; Pyridine Alkaloids ; Neurochemicals ; Acetylcholine receptor
The chemical synonyms of Lobeline hydrochloride (CAS NO.134-63-4) are 2-(6-(beta-Hydroxyphenethyl)-1-methyl-2-piperidyl)-acetophenonhydrochlor ; 2-[6-(.beta.-Hydroxyphenethyl)-1-methyl-2-piperidyl]-,hydrochloride,(-)-acetophenone ; lobelinhydrochloride ; ; lobeline Hcl, a- ; (-)-lobeline hydrochloride
Lobeline hydrochloride (CAS NO.134-63-4) is used as a neuronal nicotinic acetylcholine receptor agonist and also used as a respiratory stimulant.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
frog | LDLo | parenteral | 150mg/kg (150mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 163, Pg. 279, 1931. |
mouse | LD50 | intraperitoneal | 39900ug/kg (39.9mg/kg) | Drugs in Japan Vol. 6, Pg. 913, 1982. | |
mouse | LD50 | intravenous | 7800ug/kg (7.8mg/kg) | Drugs in Japan Vol. 6, Pg. 913, 1982. | |
mouse | LD50 | subcutaneous | 87500ug/kg (87.5mg/kg) | Drugs in Japan Vol. 6, Pg. 913, 1982. |
Poison by subcutaneous, intravenous, and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx and HCl. See also LOBELINE and CARDINAL FLOWER.
Hazard Codes:
T: Toxic
Risk Statements about Lobeline hydrochloride (CAS NO.134-63-4):
R23/25: Toxic by inhalation and if swallowed.
Safety Statements:
S45 In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.